Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal–fetal interface

Author:

de Souza Guilherme,Teixeira Samuel Cota,Fajardo Martínez Aryani Felixa,Silva Rafaela José,Luz Luana Carvalho,Lima Júnior Joed Pires de,Rosini Alessandra Monteiro,dos Santos Natália Carine Lima,de Oliveira Rafael Martins,Paschoalino Marina,Barbosa Matheus Carvalho,Alves Rosiane Nascimento,Gomes Angelica Oliveira,da Silva Claudio Vieira,Ferro Eloisa Amália Vieira,Barbosa Bellisa Freitas

Abstract

IntroductionToxoplasma gondii is the etiologic agent of toxoplasmosis, a disease that affects about one-third of the human population. Most infected individuals are asymptomatic, but severe cases can occur such as in congenital transmission, which can be aggravated in individuals infected with other pathogens, such as HIV-positive pregnant women. However, it is unknown whether infection by other pathogens, such as Trypanosoma cruzi, the etiologic agent of Chagas disease, as well as one of its proteins, P21, could aggravate T. gondii infection.MethodsIn this sense, we aimed to investigate the impact of T. cruzi and recombinant P21 (rP21) on T. gondii infection in BeWo cells and human placental explants.ResultsOur results showed that T. cruzi infection, as well as rP21, increases invasion and decreases intracellular proliferation of T. gondii in BeWo cells. The increase in invasion promoted by rP21 is dependent on its binding to CXCR4 and the actin cytoskeleton polymerization, while the decrease in proliferation is due to an arrest in the S/M phase in the parasite cell cycle, as well as interleukin (IL)-6 upregulation and IL-8 downmodulation. On the other hand, in human placental villi, rP21 can either increase or decrease T. gondii proliferation, whereas T. cruzi infection increases T. gondii proliferation. This increase can be explained by the induction of an anti-inflammatory environment through an increase in IL-4 and a decrease in IL-6, IL-8, macrophage migration inhibitory factor (MIF), and tumor necrosis factor (TNF)-α production.DiscussionIn conclusion, in situations of coinfection, the presence of T. cruzi may favor the congenital transmission of T. gondii, highlighting the importance of neonatal screening for both diseases, as well as the importance of studies with P21 as a future therapeutic target for the treatment of Chagas disease, since it can also favor T. gondii infection.

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento CientÌfico e Tecnològico

Coordenação de Aperfeiçoamento de Pessoal de NÌvel Superior

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference89 articles.

1. Toxoplasma gondii: from animals to humans;Tenter;Int J Parasitol,2000

2. Toxoplasmosis: overview from a one health perspective;Djurkovic-Djakovic;Food Waterborne Parasitol,2019

3. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots;Molan;Trop BioMed,2019

4. Congenital toxoplasmosis: the state of the art;Bollani;Front Pediatr,2022

5. Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response;Sana;Int J Immunopathol Pharmacol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3